📌 Key Takeaways
- Topic: Is Silica Soluble in Water? Solubility of Different Silica Forms Explained
- Keywords: silica bulk density
- Published: 2026-11-20 06:22:22
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silicon Dioxide CAS 7631-86-9: Identification, Properties and Regulatory Information
- Silica Gel Manufacturer: Product Types, Quality Standards and Selection Guide
- 98. Vialpando M., Albertini B., Passerini N., Bergers D., Rombaut P., Martens J.A., Mooter G.V.D. Agglomeration of mesoporous silica by melt and steam granulation: Part I: A comparison between disordered and ordered mesoporous silica. J. Pharm. Sci. 2013;102:3966-3977. doi: 10.1002/jps.23700. [ DOI ] [ PubMed ] [ Google Scholar ]
- Transparent Silica Filler: How to Keep Clarity in Coatings and Resins
- Silica for Sunscreen: How It Improves Feel, Dispersion and SPF Performance
- Silica for Adhesives: Thickening, Thixotropy and Reinforcement Explained
Silica for HPLC: Particle Types, Pore Sizes and Column Performance
What is silica (SiO₂)?
silica testing method Wet granulation is the most frequently used technique to process MSNs, because of the many possibilities inherent in it [ 106 ]. Conventional wet granulation is well-suited for the granulation of silica nanocarriers, but several things should be considered during implementation. There are two possible sequences: first, the drug loading, followed by the granulation of the loaded carriers [ 104 ], or the opposite way, the granulation of the empty carriers, then loading the drug into the prepared granules. In the first case, during the planning and implementation of the process, special attention must be paid to the critical process parameters to steer clear of premature drug release [ 104 ]. In general, it can be noted that as little moisture as possible should be used during granulation, consequently decreasing the risk of premature drug release. Still, simultaneously, moisture adequate to produce the desired agglomeration must be made sure [ 104 ]. The risk of premature drug release depends to a certain extent on the chemical structure of the API and the carrier. Szewczyk and Prokopowicz developed doxycycline-loaded MSN pellets with prolonged release kinetics [ 40 ]. First, the drug was loaded into the pores, and then pellets were produced from the loaded mesoporous material with other excipients by wet extrusion and spheronization. For comparison, traditional doxycycline pellets were also prepared. This study demonstrated the importance of utilizing mesoporous carriers for the delayed or sustained release of water-soluble drugs. Pelletization was a successful method to reduce the initial burst release of doxycycline; twice the release time was observed compared to traditional pellets [ 40 ]. Szewczyk et al. developed another DDS loaded with an antibiotic compound (cefazolin) for the treatment of osteomyelitis [ 66 ]. The amine-functionalized MSN was successfully loaded with the drug, and because of the powerful interactions between the negatively charged cefazolin and the positively charged surface of the carrier, a prolonged release of 5 days was observed, which made sure a longer antibacterial influence than with classic pellets. This was proven by the microbiological activity assays of the pellets against S. aureus culture [ 66 ]. These results are promising in antibiotic or anticancer therapy, where therapeutic concentration is needed for a longer period [ 40, 66 ]. A comparable outcome was presented in another publication about metformin-containing MSN pellets with prolonged release kinetics [ 85 ]. After drug loading, pellets were formed with the mixture of the preloaded carriers and chitosan solution, and then the pellets were coated with five layers of chitosan. Since the stomach is not considered the best possible absorption surface for metformin, it is advisable to delay the release until conditions in the intestines are ideal for maximum bioavailability. Chitosan plays an important role in this formulation; it slows down and delays the metformin release and offers delayed and prolonged release kinetics, thereby preventing speedy blood level peaks after application [ 85 ]. On the contrary, Wang et al. published a post on MSN pellets filled with poorly water-soluble carbamazepine, and they observed better oral bioavailability compared to commercially available tablets based on in vivo analysis performed on dogs [ 86 ]. In vitro dissolution studies confirmed a raised dissolution rate compared to crystalline carbamazepine due to the amorphous state of the drug within the pores. This immediate-release pellet formulation allows for a reduction in the drug dose, sustaining the same clinical influence [ 86 ].
What is the difference between fumed silica and precipitated silica?
silica flow agent
What drives silica raw material prices?
silica manufacturer China The potential of MSNs may also be utilized well in the case of polypills. In this case, all drugs must be dissolved in the solvent. After that, the carriers must be loaded with this complex solution, employing one of the already mentioned drug loading techniques. This can be followed by tableting nanocarriers. This approach can be really beneficial in the treatment of hypertension, where combination therapy is most often used. Patient compliance could also be improved with the production of such a polypill, since taking one pill rather than multiple pills may be simpler for the combined treatment of high blood pressure [ 99 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.